ARALEZ PHARMACEUTICALS INC COM SHS (ARLZQ)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Adrian Adams
Employees:
105
7100 WEST CREDIT AVENUE, SUITE 101, MISSISSAUGA, CANADA L5N 0E4
905-876-1118

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Aralez Pharmaceuticals Inc. operates as a pharmaceutical company. It focuses on the development, acquisition, and commercialization of cardiovascular, pain, and other product therapies. The company is founded on December 2, 2015 and is headquartered in Ontario, Canada.^ ^ ^ ^ ^ ^ ^

Data derived from most recent annual or quarterly report
Market Cap 2.352 Million Shares Outstanding67.194 Million Avg 30-day Volume 5.195 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-1.76
Price to Revenue0.0 Debt to Equity18.7941 EBITDA-59.914 Million
Price to Book Value0.0 Operating Margin-91.0861 Enterprise Value0
Current Ratio0.776 EPS Growth-0.086 Quick Ratio0.624
1 Yr BETA 1.2156 52-week High/Low 0.0 / Profit Margin-118.177
Operating Cash Flow Growth65.6209 Free Cash Flow to Firm (FCFF) TTM -493.1 Thousand Free Cash Flow to Equity (FCFE) TTM-68.851 Million
Altman Z-Score0.0
View SEC Filings from ARLZQ instead.

View recent insider trading info

ARALEZ PHARMACEUTICALS INC COM SHS YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ARLZQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARLZQ

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2018-06-06 by KOVEN ANDREW I
  • 4: filed on 2018-05-16 by KOVEN ANDREW I
  • 4: filed on 2018-05-16 by TURSI JAMES PATRICK
  • 4: filed on 2018-03-21 by TURSI JAMES PATRICK
  • 4: filed on 2018-03-21 by KOVEN ANDREW I
  • 4: filed on 2017-12-12 by KIRSCH ARTHUR S
  • 4: filed on 2017-12-04 by KASETA MICHAEL
  • 3: filed on 2017-12-04 by KASETA MICHAEL
  • 4: filed on 2017-10-04 by TURSI JAMES PATRICK
  • 4: filed on 2017-07-28 by CHARLES SCOTT J

    • Events (8k)

  • 8-K: filed on 2019-05-30:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-05-13:
    Item 8.01: Other Events
  • 8-K: filed on 2019-03-07:
    Item 2.01: Completion of Acquisition or Disposition of Assets
  • 8-K: filed on 2019-02-06:
    Item 8.01: Other Events
  • 8-K: filed on 2019-01-18:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2018-12-12:
    Item 1.01: Entry into a Material Definitive Agreement
  • 8-K: filed on 2018-11-02:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-10-05:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-05-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-03-14:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    KOVEN ANDREW I PRESIDENT & CHIEF BUSINESS OFF

    • Officer
    		 1,183,419 2018-06-04 0

    TURSI JAMES PATRICK CHIEF MEDICAL OFFICER

    • Officer
    		 242,052 2018-05-14 0

    GLICKMAN MARK A CHIEF COMMERCIAL OFFICER

    • Officer
    		 250,188 2018-03-19 0

    TRACHTENBERG ERIC GC, CCO & SECRETARY

    • Officer
    		 198,093 2018-03-19 0

    KASETA MICHAEL CHIEF FINANCIAL OFFICER

    • Officer
    		 15,000 2018-03-15 0

    KIRSCH ARTHUR S

    • Director
    		 276,609 2017-12-08 0

    CHARLES SCOTT J CHIEF FINANCIAL OFFICER

    • Officer
    		 280,551 2017-07-28 0

    ARYEH JASON

    • Director
    		 15,000 2017-05-19 0

    RUDNICK SETH

    • Director
    		 116,891 2017-05-11 0

    LEE KENNETH B JR

    • Director
    		 102,952 2017-05-11 0

    ADAMS ADRIAN CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 3,787,610 2017-05-11 0

    THRASHER FRANCIS MARTIN

    • Director
    		 292,178 2017-05-11 0

    FOWLER NEAL FRANKLIN

    • Director
    		 73,869 2017-05-11 0

    ARMSTRONG JENNIFER LOU EVP HR AND ADMINISTRATION

    • Officer
    		 156,825 2017-05-11 0

    HARRIS ROBERT PAUL

    • Director
    		 1,201,782 2017-05-11 0

    QLT INC/BC

    • 10% Owner
    		 No longer subject to file 2016-03-17 0

    PAR INVESTMENT PARTNERS LP

    PAR GROUP, L.P.

    PAR CAPITAL MANAGEMENT INC

    • 10% Owner
    		 No longer subject to file 2016-02-05 0

    BARNHARDT JOHN E VP, FINANCE AND ADMINISTRATION

    • Officer
    		 75,528 2016-02-05 0

    HODGES WILLIAM L CHIEF FINANCIAL OFFICER

    • Officer
    		 No longer subject to file 2015-12-31 0

    THOMAS GILDA MARIE SR, VP, GEN CNSL & SECRETARY

    • Officer
    		 No longer subject to file 2015-12-31 0

    FORT JOHN G. CHIEF MEDICAL OFFICER

    • Officer
    		 No longer subject to file 2015-12-31 0

    MCNAMARA DENNIS L SVP & CHIEF BUSINESS OFFICER

    • Officer
    		 No longer subject to file 2015-12-31 0

    PLACHETKA JOHN R

    • 10% Owner
    		 3,138,771 2015-12-03 0

    NICKLASSON MARTIN

    • Director
    		 12,500 2013-06-06 0

    CERMAK ELIZABETH EVP, CHIEF COMMERCIAL OFFICER

    • Officer
    		 20,000 2013-03-15 0

    REJEANGE JACQUES

    • Director
    		 22,200 2012-06-07 0

    BOCANEGRA TOMAS S. EVP, DEVELOPMENT

    • Officer
    		 15,750 2012-03-15 0

    MAUZEY JAMES JOSEPH

    • Director
    		 13,000 2011-06-09 0

    LARSON ANGELA MARIA

    • Director
    		 8,000 2011-06-09 0

    ORLEMANS EVERARDUS SR. VP, PRODUCT DEVELOPMENT

    • Officer
    		 0 2010-03-15 0

    RIZZO PAUL J

    • Director
    		 4,000 2009-06-03 0

    WISE PETER J

    • Director
    		 259,254 2008-05-16 0

    TOMASON BRUCE A

    • Director
    		 4,000 2008-05-06 0

    REESE MARSHALL E EXEC VP, PROD DEV

    • Officer
    		 0 2008-05-06 0

    ADOMONIS KRISTINA M SENIOR VP, BUSINESS DEV

    • Officer
    		 78,125 2006-10-23 0

    NAMM DONALD H

    • Director
    		 0 2006-03-14 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments